Company lists · Data refreshed September 2026

Top 25 Cancer drug developers based in New York, United States

Name: Cancer drug developers based in New York, United States
Creator: RevenueBase
License: https://creativecommons.org/licenses/by/4.0/

Compiled by the RevenueBase Data Team Data refreshed Sep 19, 2026 49 companies tracked

RevenueBase identified 49 cancer drug developers headquartered in New York, United States as of September 2026 and tracks 2,161 professional contacts across them, including 940 with verified work emails. San Diego is the largest hub.

This list covers cancer drug developers headquartered in New York, United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 19, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 19, 2026 86% judged on-target in blind review

49Companies

2,161Contacts tracked

940Verified emails

Explore this list → Free signup · no credit card · 500 free credits

The 25 largest cancer drug developers based in New York, United States

Ranked by team size

Top 25 of 49 cancer drug developers based in New York, United States, ranked by team size, largest first. Data refreshed Sep 19, 2026. RevenueBase Smart Search rates how each company's information relates to cancer drug developers: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#	Company	RevenueBase Smart Search	Headquarters	Employees	Contacts
1	Menarini Stemline	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	501-1,000	677 contacts →
	Indirect evidence “The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.("Stemline"), a wholly-owned subsidiary of the Menarini…” Source: RevenueBase Database · checked Sep 19, 2026
2	Syndax Pharmaceuticals	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	51-200	336 contacts →
	Partial evidence “Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies.” Source: RevenueBase Database · checked Sep 19, 2026
3	Nuvation BIO	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	51-200	215 contacts →
	Partial evidence “Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment with the goal of developing therapies that create a profound…” Source: RevenueBase Database · checked Sep 19, 2026
4	Ludwig Cancer Research	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	501-1,000	201 contacts →
	Partial evidence “Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years.” Source: RevenueBase Database · checked Sep 19, 2026
5	IGI	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	51-200	130 contacts →
	Indirect evidence “IGI, Inc.” Source: RevenueBase Database · checked Sep 19, 2026
6	Y-Mabs Therapeutics, INC	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	51-200	88 contacts →
	Indirect evidence “Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of…” Source: RevenueBase Database · checked Sep 19, 2026
7	Actinium Pharmaceuticals, INC	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	52 contacts →
	Partial evidence “Actinium is a pioneer in targeted radiotherapies designed to improve outcomes for patients with cancer.” Source: RevenueBase Database · checked Sep 19, 2026
8	Medivation	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	501-1,000	52 contacts →
	Indirect evidence “Medivation Inc, which is now a part of Pfizer, Inc.” Source: RevenueBase Database · checked Sep 19, 2026
9	Protara Therapeutics	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	49 contacts →
	Partial evidence “Protara is committed to advancing transformative therapies for people with cancer and rare diseases.” Source: RevenueBase Database · checked Sep 19, 2026
10	Volastra Therapeutics	Strong evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	47 contacts →
	Strong evidence “Volastra Therapeutics is a New York-based drug discovery and therapeutics company pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN)…” Source: RevenueBase Database · checked Sep 19, 2026
11	Oncoprecision	Strong evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	24 contacts →
	Strong evidence “OncoPrecision is a precision oncology company engineering first-in-class antibody-drug conjugates (ADCs) and bispecific antibodies for hard-to-treat cancers.” Source: RevenueBase Database · checked Sep 19, 2026
12	Beyondspring	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	20 contacts →
	Partial evidence “BeyondSpring Pharmaceuticals is a global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes.” Source: RevenueBase Database · checked Sep 19, 2026
13	Treadwell Therapeutics, INC	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	20 contacts →
	Partial evidence “Treadwell Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities…” Source: RevenueBase Database · checked Sep 19, 2026
14	Oncusp Therapeutics	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	19 contacts →
	Indirect evidence “OnCusp Therapeutics, Inc.” Source: RevenueBase Database · checked Sep 19, 2026
15	Promontory Therapeutics	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	17 contacts →
	Indirect evidence “Promontory Therapeutics is a private, clinical stage biopharmaceutical company founded in 2010, and funded by private investors and family investment offices in the U.S, Europe…” Source: RevenueBase Database · checked Sep 19, 2026
16	Stelexis Biosciences, INC	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	16 contacts →
	Partial evidence “Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through…” Source: RevenueBase Database · checked Sep 19, 2026
17	Inspirna, INC	Strong evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	15 contacts →
	Strong evidence “Inspirna, Inc, is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of…” Source: RevenueBase Database · checked Sep 19, 2026
18	The Mark Foundation For Cancer Research	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	1-10	12 contacts →
	Partial evidence “The Mark Foundation for Cancer Research actively partners with scientists to accelerate research that will transform the prevention, diagnosis, and treatment of cancer.” Source: RevenueBase Database · checked Sep 19, 2026
19	Hemogenyx Pharmaceuticals	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	8 contacts →
	Indirect evidence “Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC…” Source: RevenueBase Database · checked Sep 19, 2026
20	Star Health Network, INC	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	11-50	8 contacts →
	Indirect evidence “Star Health Network is a New York City based company that has created a worldwide establishment of Laboratories, Hospitals, Oncologists, Captive Audience of Patients & a Full…” Source: RevenueBase Database · checked Sep 19, 2026
21	Frezent Biological	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	1-10	8 contacts →
	Partial evidence “Despite advances in cancer therapy, recurrence remains a major unmet need and a leading cause of cancer-related mortality.” Source: RevenueBase Database · checked Sep 19, 2026
22	Humane Genomics	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	1-10	6 contacts →
	Partial evidence “Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency.” Source: RevenueBase Database · checked Sep 19, 2026
23	Hoth Therapeutics, INC	Indirect evidence	New York, NY, United StatesHQ checked Sep 19, 2026	1-10	6 contacts →
	Indirect evidence “At Hoth Therapeutics, Inc.(NASDAQ: HOTH), we strive to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life.” Source: RevenueBase Database · checked Sep 19, 2026
24	OS Therapies	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	1-10	6 contacts →
	Partial evidence “OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies…” Source: RevenueBase Database · checked Sep 19, 2026
25	TFC Therapeutics	Partial evidence	New York, NY, United StatesHQ checked Sep 19, 2026	1-10	5 contacts →
	Partial evidence “TFC Therapeutics is developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis.” Source: RevenueBase Database · checked Sep 19, 2026

RevenueBase Smart Search

RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: cancer drug developers. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.

Strong evidence: The company's own public description of its business names cancer drug developers.
Partial evidence: Its own public description names part of cancer drug developers, so it works in or next to the category without describing itself that way.
Indirect evidence: The description shown does not name cancer drug developers. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.

RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.

Showing 25 of 49 cancer drug developers based in New York, United States

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 940 reachable decision-makers.

Free signup · no credit card

View the full list →

Cancer drug developers based in New York, United States at a glance

As of Sep 19, 2026

43.5%Verified-email coverage

44.1Average contacts per company

11-50Median size (employees)

149.0%Largest-city concentration · San Diego

Sep 19, 2026Page data refreshed

Companies by employee count

1-10

11-50

51-200

501-1,000

Email recency for this list is measured across the whole United States list rather than for New York, so it is reported there. Company counts and contact totals on this page are exact for New York, over 49 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among cancer drug developers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source: The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies: Companies headquartered in New York, United States whose own description of what they do matches “cancer drug developers”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search: RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names cancer drug developers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude: Companies whose own description does not clearly place them among cancer drug developers, and records with no verified work email. Companies headquartered outside New York are excluded even when they keep an office there.
Match quality: In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking: Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification: Every listed company carries at least one verified work email, 940 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh: This page's figures were pulled from the company graph on September 19, 2026. Lists refresh periodically as the graph is re-checked.
Corrections: Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Cancer drug developers by metro in the United States

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names cancer drug developers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many cancer drug developers are there based in New York, United States?

RevenueBase identified 49 cancer drug developers headquartered in New York, United States as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Menarini Stemline, headquartered in New York, tops this list with the largest team on record.

Which city has the most cancer drug developers?

San Diego leads with 73 headquartered companies, followed by Cambridge (55) and New York (49).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 940 verified decision-maker contacts tracked across these 49 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 19, 2026.

Ready to reach these companies? Verified emails and direct dials for all 49 cancer drug developers based in New York, United States. Start with a free account, no credit card.

Download this list →

Related lists

Cancer drug developers by geography

Browse the directory

Browse: Companies home · Cancer drug developers in United States · All United States lists · All Cancer drug developers lists · New lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.